Joseph P. O'Connell
2018 - Odonate Therapeutics
In 2018, Joseph P. O'Connell earned a total compensation of $1.4M as Chief Medical Officer at Odonate Therapeutics, a 48% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $113,056 |
|---|---|
| Option Awards | $944,898 |
| Salary | $353,300 |
| Other | $35,578 |
| Total | $1,446,832 |
O'Connell received $944.9K in option awards, accounting for 65% of the total pay in 2018.
O'Connell also received $113.1K in non-equity incentive plan, $353.3K in salary and $35.6K in other compensation.
Rankings
In 2018, Joseph P. O'Connell's compensation ranked 7,331st out of 14,244 executives tracked by ExecPay. In other words, O'Connell earned more than 48.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,331 out of 14,244 | 49th |
Division Manufacturing | 2,841 out of 5,765 | 51st |
Major group Chemicals And Allied Products | 1,068 out of 2,128 | 50th |
Industry group Drugs | 903 out of 1,817 | 50th |
Industry Pharmaceutical Preparations | 707 out of 1,391 | 49th |
Source: SEC filing on June 24, 2019.
O'Connell's colleagues
We found two more compensation records of executives who worked with Joseph P. O'Connell at Odonate Therapeutics in 2018.
News
Odonate Therapeutics Chief Medical Officer Joseph O'Connell's 2020 pay falls 31% to $1.4M
June 1, 2021
Odonate Therapeutics Chief Medical Officer Joseph O'Connell's 2019 pay jumps 37% to $2M
May 15, 2020
Odonate Therapeutics Chief Medical Officer Joseph O'Connell's 2018 pay jumps 465% to $1.4M
June 24, 2019